CONMED CORPORATION Finance Lease, Right-of-Use Asset, after Accumulated Amortization
CONMED CORPORATION (CNMD) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $1.98 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-02-17
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.98M.
- 2024-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $2.34M.
- 2023-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $2.60M.
- 2022-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $414.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2025-12-31 | $1.98M 10-K · filed 2026-02-17 |
| 2024-12-31 | $2.34M 10-K · filed 2026-02-17 |
| 2023-12-31 | $2.60M 10-K · filed 2025-02-18 |
| 2022-12-31 | $414.00K 10-K · filed 2024-02-28 |
| 2021-12-31 | $839.00K 10-K · filed 2023-02-21 |
| 2020-12-31 | $937.00K 10-K · filed 2022-02-22 |
| 2019-12-31 | $1.21M 10-K · filed 2021-02-22 |
| 2019-09-30 | $768.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $819.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $829.00K 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |